Status
Acquired by Bristol-Myers Squibb on April 29, 2014
Funding Received
$74.2 Million in 4 Rounds from 8 Investors
Headquarters:
South San Francisco, CA
Description:
iPierian is a drug discovery platform developing therapies for neurodegenerative diseases such as SMA, ALS and Parkinson’s.
Categories:
Biotechnology
Website:
http://www.ipierian.com

Current Team (6)

Update

Acquisitions (1)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • HQ

    951 Gateway Blvd.

    South San Francisco, CA 94080

    USA

Images (1)

Update
  • C297ee884f68e6eda1b90bffd3735f9f